Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Gundert-Remy

Showing results (31-40 of 267) with videos related to

Pageof 27
Sort By:
Archives of Toxicology|June 12, 2014
Internal threshold of toxicological concern values: enabling route-to-route extrapolationFalko Partosch, Hans Mielke, Ralf Stahlmann, et al.
Archives of Toxicology|November 24, 2018
In vitro proteomic analysis of methapyrilene toxicity in rat hepatocytes reveals effects on intermediary metabolismAlbert Braeuning, Axel Oberemm, Tanja Heise, et al.
Deutsches Arzteblatt International|May 22, 2010
The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publicationGisela Schott, Henry Pachl, Ulrich Limbach, et al.
Deutsches Arzteblatt International|May 15, 2010
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trialsGisela Schott, Henry Pachl, Ulrich Limbach, et al.
Archives of Toxicology|November 4, 2010
A physiologically based toxicokinetic modelling approach to predict relevant concentrations for in vitro testingHans Mielke, Lennart T Anger, Markus Schug, et al.
Toxicology Letters|February 5, 2011
Physiologically based toxicokinetic modelling as a tool to assess target organ toxicity in route-to-route extrapolation--the case of coumarinHans Mielke, Klaus Abraham, Mario Götz, et al.
Frontiers in Toxicology|August 4, 2022
<i>In Vitro</i>-<i>In Vivo</i> Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons LearnedEngi Abdelhady Algharably, Emma Di Consiglio, Emanuela Testai, et al.
Archives of Toxicology|February 19, 2021
Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro-in vivo extrapolationEngi Abd El-Hady Algharably, Emma Di Consiglio, Emanuela Testai, et al.
Archives of Toxicology|April 18, 2008
Human CYP2E1 mediates the formation of glycidamide from acrylamideEva Settels, Ulrike Bernauer, Richard Palavinskas, et al.
Alternatives to Laboratory Animals : ATLA|October 14, 2005
Heterologous expression of mouse cytochrome P450 2e1 in V79 cells: construction and characterisation of the cell line and comparison with V79 cell lines stably expressing rat P450 2E1 and human P450 2E1Ulrike Bernauer, Hansruedi Glatt, Barbara Heinrich-Hirsch, et al.
Pageof 27

Showing results (31-40 of 267) with videos related to

Sort By:
Pageof 27
Archives of Toxicology|June 12, 2014
Internal threshold of toxicological concern values: enabling route-to-route extrapolationFalko Partosch, Hans Mielke, Ralf Stahlmann, et al.
Archives of Toxicology|November 24, 2018
In vitro proteomic analysis of methapyrilene toxicity in rat hepatocytes reveals effects on intermediary metabolismAlbert Braeuning, Axel Oberemm, Tanja Heise, et al.
Deutsches Arzteblatt International|May 22, 2010
The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publicationGisela Schott, Henry Pachl, Ulrich Limbach, et al.
Deutsches Arzteblatt International|May 15, 2010
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trialsGisela Schott, Henry Pachl, Ulrich Limbach, et al.
Archives of Toxicology|November 4, 2010
A physiologically based toxicokinetic modelling approach to predict relevant concentrations for in vitro testingHans Mielke, Lennart T Anger, Markus Schug, et al.
Toxicology Letters|February 5, 2011
Physiologically based toxicokinetic modelling as a tool to assess target organ toxicity in route-to-route extrapolation--the case of coumarinHans Mielke, Klaus Abraham, Mario Götz, et al.
Frontiers in Toxicology|August 4, 2022
<i>In Vitro</i>-<i>In Vivo</i> Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons LearnedEngi Abdelhady Algharably, Emma Di Consiglio, Emanuela Testai, et al.
Archives of Toxicology|February 19, 2021
Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro-in vivo extrapolationEngi Abd El-Hady Algharably, Emma Di Consiglio, Emanuela Testai, et al.
Archives of Toxicology|April 18, 2008
Human CYP2E1 mediates the formation of glycidamide from acrylamideEva Settels, Ulrike Bernauer, Richard Palavinskas, et al.
Alternatives to Laboratory Animals : ATLA|October 14, 2005
Heterologous expression of mouse cytochrome P450 2e1 in V79 cells: construction and characterisation of the cell line and comparison with V79 cell lines stably expressing rat P450 2E1 and human P450 2E1Ulrike Bernauer, Hansruedi Glatt, Barbara Heinrich-Hirsch, et al.
Pageof 27